test

Neb Obradovic

@Cormorant Asset Management, Lp

Latest period2024 - Q3ReportedManaged Assets$1.886BTotal holdings45
Assets growth rate8.94%Assets growth rate (2-Q avg)-7.56%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Cormorant Asset Management, Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 45 positions.

Assets under management

The assets under management (AUM) of Cormorant Asset Management, Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.886B in assets, with a quarterly growth rate of 8.94% and a 2-quarter average growth rate of -7.56%. The portfolio is managed by Neb Obradovic, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
SRPTSarepta Therapeutics Inc
Recent Activity
Exited
0%
$19.75M
125,000 shares@ $158.0 avg price
CGEMCullinan Therapeutics Inc
Recent Activity
Exited
0%
$19.62M
1.125M shares@ $17.44 avg price
IDYAIdeaya Biosciences Inc
Recent Activity
Exited
0%
$8.602M
245,000 shares@ $35.11 avg price
IBRXImmunitybio Inc
Recent Activity
Exited
0%
$7.9M Put
1.25M shares@ $6.32 avg price
LNTHLantheus Hldgs Inc
Recent Activity
Exited
0%
$6.022M
75,000 shares@ $80.29 avg price
MRSNMersana Therapeutics Inc
Recent Activity
Exited
0%
$5.226M
2.6M shares@ $2.01 avg price
SIGASiga Technologies Inc
Recent Activity
Exited
0%
$3.795M Put
500,000 shares@ $7.59 avg price
CMPXCompass Therapeutics Inc
Recent Activity
Exited
0%
$2.031M
2.031M shares@ $1.0 avg price